Zurich Cantonal Bank
CGEM icon

Zurich Cantonal Bank’s Cullinan Oncology CGEM Stock Holding History

Zurich Cantonal Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
20,348
+1,281
+7% +$19K ﹤0.01% 2098
2026
Q1 		$271K Buy
19,067
+9,158
+92% +$118K ﹤0.01% 2140
2025
Q4 		$103K Buy
9,909
+2,268
+30% +$20.5K ﹤0.01% 2386
2025
Q3 		$45.3K Hold
7,641
– – ﹤0.01% 2458
2025
Q2 		$57.5K Hold
7,641
– – ﹤0.01% 2457
2025
Q1 		$57.8K Sell
7,641
-1,008
-12% -$9.67K ﹤0.01% 2500
2024
Q4 		$105K Sell
8,649
-234
-3% -$3.36K ﹤0.01% 2414
2024
Q3 		$149K Hold
8,883
– – ﹤0.01% 2265
2024
Q2 		$155K Buy
8,883
+3,758
+73% +$80K ﹤0.01% 2164
2024
Q1 		$87.3K Sell
5,125
-1,417
-22% -$21.9K ﹤0.01% 2433
2023
Q4 		$66.7K Hold
6,542
– – ﹤0.01% 2553
2023
Q3 		$59.2K Buy
6,542
+6,085
+1,332% +$63.4K ﹤0.01% 2555
2023
Q2 		$4.92K Hold
457
– – ﹤0.01% 2762
2023
Q1 		$4.67K Hold
457
– – ﹤0.01% 2817
2022
Q4 		$4.82K Sell
457
-3,261
-88% -$39.6K ﹤0.01% 2826
2022
Q3 		$48K Buy
+3,718
New +$50.1K ﹤0.01% 2606

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Zurich Cantonal Bank's CGEM Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Cullinan Oncology (CGEM) stake by 6.7% in Q2 2026, buying an estimated $19K and bringing the position to 20,348 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Zurich Cantonal Bank first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Zurich Cantonal Bank held 20,348 shares of Cullinan Oncology worth $371K as of Q2 2026.
  • Zurich Cantonal Bank bought 1,281 Cullinan Oncology shares in Q2 2026, an estimated $19K.
  • Cullinan Oncology made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2098 holding.
  • Zurich Cantonal Bank first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.